Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label safety and efficacy of brivaracetam tablets in partial-onset seizures
CTR20251644Phase 3Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Apr 2025; status: active.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on CTR20251644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251644.